G R Warnick

Summary

Publications

  1. ncbi Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays
    G R Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 St, Issaquah, WA 98027, USA
    Clin Chem 47:1579-96. 2001
  2. ncbi Measurement of cholesterol in plasma and other body fluids
    G R Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 Street, Issaquah, WA 98027, USA
    Curr Atheroscler Rep 3:404-11. 2001
  3. ncbi Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory
    G Russell Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 St, Issaquah, WA 98027, USA
    Clin Chem 48:11-7. 2002
  4. ncbi Quality specifications and the assessment of the biochemical risk of atherosclerosis
    Nader Rifai
    Children s Hospital, Boston, MA 02115, USA
    Clin Chim Acta 346:55-64. 2004
  5. ncbi Clinical Chemistry journal has contributed to progress in lipid and lipoprotein testing for fifty years
    Nader Rifai
    Children's Hospital, Department of Laboratory Medicine, Boston, MA 02115, USA
    Clin Chem 50:1861-70. 2004
  6. ncbi Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults
    Richard B Lanman
    diaDexus, Inc, South San Francisco, CA 94080, USA
    Prev Cardiol 9:138-43. 2006
  7. ncbi Fasting versus nonfasting triglycerides: implications for laboratory measurements
    G Russell Warnick
    Berkeley HeartLab, 960 Atlantic Avenue, Alameda, CA 94501, USA
    Clin Chem 54:14-6. 2008
  8. ncbi Estimation of LDL-associated apolipoprotein B from measurements of triglycerides and total apolipoprotein B
    Arthur M Baca
    Berkeley HeartLab Inc, Alameda, CA 94501, USA
    Clin Chem 54:907-10. 2008

Collaborators

Detail Information

Publications8

  1. ncbi Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays
    G R Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 St, Issaquah, WA 98027, USA
    Clin Chem 47:1579-96. 2001
    ..This review provides an overview of the new generation of homogeneous assays for HDL-C within the historical context of the evolution of methods and the efforts to standardize measurements of the lipoproteins...
  2. ncbi Measurement of cholesterol in plasma and other body fluids
    G R Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 Street, Issaquah, WA 98027, USA
    Curr Atheroscler Rep 3:404-11. 2001
    ..Efforts continue to develop reliable, minimally invasive tests in body fluids other than serum...
  3. ncbi Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory
    G Russell Warnick
    Pacific Biometrics Research Foundation, 24415 SE 156 St, Issaquah, WA 98027, USA
    Clin Chem 48:11-7. 2002
    ..The implications for clinical laboratories are summarized in this report...
  4. ncbi Quality specifications and the assessment of the biochemical risk of atherosclerosis
    Nader Rifai
    Children s Hospital, Boston, MA 02115, USA
    Clin Chim Acta 346:55-64. 2004
    ....
  5. ncbi Clinical Chemistry journal has contributed to progress in lipid and lipoprotein testing for fifty years
    Nader Rifai
    Children's Hospital, Department of Laboratory Medicine, Boston, MA 02115, USA
    Clin Chem 50:1861-70. 2004
  6. ncbi Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults
    Richard B Lanman
    diaDexus, Inc, South San Francisco, CA 94080, USA
    Prev Cardiol 9:138-43. 2006
    ....
  7. ncbi Fasting versus nonfasting triglycerides: implications for laboratory measurements
    G Russell Warnick
    Berkeley HeartLab, 960 Atlantic Avenue, Alameda, CA 94501, USA
    Clin Chem 54:14-6. 2008
  8. ncbi Estimation of LDL-associated apolipoprotein B from measurements of triglycerides and total apolipoprotein B
    Arthur M Baca
    Berkeley HeartLab Inc, Alameda, CA 94501, USA
    Clin Chem 54:907-10. 2008
    ..Ultracentrifugation of samples enriched in chylomicrons and VLDL and subsequent measurement of apo B in the infranate fraction [density (d) = 1.006] removes this interference. This apo B fraction is called "LDL-apo B."..